My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Actiq 800 micrograms compressed lozenge with integral oromucosal applicator



Teva Pharma B.V.PA0749/195/004

Main Information

Trade NameActiq 800 micrograms compressed lozenge with integral oromucosal applicator
Active SubstancesFentanyl
Dosage FormCompressed lozenge
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/195/004

Group Information

ATC CodeN02AB Phenylpiperidine derivatives
N02AB03 fentanyl

Status

License statusWithdrawn
Withdrawn Date11/03/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

HPRA approval pending

Educational Materials - Patient

HPRA pending approval
« Back
Follow medicine

Print